ArticleGastroenterology2011

MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.

Sei-Jung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.